Patents by Inventor Terrence Hunt

Terrence Hunt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SCREENING ASSAY TO ASSESS TOPICAL DELIVERY OF BIOLOGICAL THERAPEUTIC AGENTS
    Publication number: 20210275691
    Abstract: An in vivo assay to evaluate topical delivery of a biologic agent from a formulation is provided. The assay comprises treating a skin area of a CD hairless rat with tape stripping to disrupt the stratum corneum in the skin area to define a treated skin area and topically applying a formulation to the treated skin area. The formulation, in one embodiment, comprises the biologic agent and a pharmaceutically acceptable carrier. Delivery of the biologic agent into the skin from the topically applied formulation is evaluated via in vitro or in vivo techniques.
    Type: Application
    Filed: May 30, 2019
    Publication date: September 9, 2021
    Inventors: Jie Shen, Hsiang Ho, Lydia Andrew-Jones, Betsy Bloom, Greg Nicholson, Lance Steward, Amy Brideau-Anderson, Terrence Hunt, Ron Broide, David Rupp, David Canty
  • FORMULATIONS OF BIOLOGICS FOR INTRAVESICAL INSTILLATION
    Publication number: 20190022195
    Abstract: Pharmaceutical formulations comprising a clostridial derivative and a permeabilizing agent for intravesical instillation are disclosed.
    Type: Application
    Filed: April 16, 2018
    Publication date: January 24, 2019
    Inventors: Eric A. Forssen, Patrick M. Hughes, David C. Rupp, Terrence Hunt, Gary Shimizu, Joseph Francis, Ron S. Broide, Ester Fernandez-Salas
  • Formulations of biologics for intravesical instillation
    Patent number: 9943576
    Abstract: Pharmaceutical formulations comprising a clostridial derivative and a permeabilizing agent for intravesical instillation are disclosed.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: April 17, 2018
    Assignee: Allergan, Inc.
    Inventors: Eric A. Forssen, Patrick M. Hughes, David C. Rupp, Terrence Hunt, Gary Shimizu, Joseph Francis, Ron S. Broide, Ester Fernandez-Salas
  • FORMULATIONS OF BIOLOGICS FOR INTRAVESICAL INSTILLATION
    Publication number: 20150313973
    Abstract: Pharmaceutical formulations comprising a clostridial derivative and a permeabilizing agent for intravesical instillation are disclosed.
    Type: Application
    Filed: April 30, 2015
    Publication date: November 5, 2015
    Inventors: Eric A. Forssen, Patrick M. Hughes, David C. Rupp, Terrence Hunt, Gary Shimizu, Joseph Francis, Ron S. Broide, Ester Fernandez-Salas
  • PHARMACEUTICAL COMPOSITIONS CONTAINING BOTULINUM TOXIN
    Publication number: 20080108570
    Abstract: This invention relates to the use of a composition comprising a polysaccharide and a botulinum toxin for reducing a skin wrinkle. In some embodiments, the polysaccharide comprises disaccharides. In some embodiments, the average molecular weight of a disaccharide unit of the polysaccharide is between about 345 D and about 1,000 D.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 8, 2008
    Applicant: ALLERGAN, INC.
    Inventor: Terrence Hunt
  • Pharmaceutical Compositions Containing Botulinum Toxin
    Publication number: 20070081960
    Abstract: This invention relates to the use of a composition comprising a polysaccharide and a botulinum toxin for reducing a skin wrinkle. In some embodiments, the polysaccharide comprises disaccharides. In some embodiments, the average molecular weight of a disaccharide unit of the polysaccharide is between about 345 D and about 1,000 D.
    Type: Application
    Filed: October 9, 2006
    Publication date: April 12, 2007
    Applicant: ALLERGAN, INC.
    Inventor: Terrence Hunt
  • Botulinum toxin compositions
    Publication number: 20070026019
    Abstract: A high potency botulinum toxin pharmaceutical composition comprising two excipients (such as albumin and sodium chloride) in a weight to weight ratio of between about 1 and about 100.
    Type: Application
    Filed: August 1, 2005
    Publication date: February 1, 2007
    Applicant: ALLERGAN, INC.
    Inventor: Terrence Hunt
  • Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
    Publication number: 20060269575
    Abstract: A botulinum toxin pharmaceutical composition comprising a botulinum toxin and a non-pasteurized recombinant albumin. In some embodiments, the pharmaceutical composition comprises a reduced amount of recombinant albumin aggregates.
    Type: Application
    Filed: August 4, 2006
    Publication date: November 30, 2006
    Applicant: ALLERGAN, INC.
    Inventor: Terrence Hunt
  • Clostridial toxin pharmaceutical composition containing a gelatin fragment
    Publication number: 20060104994
    Abstract: A botulinum toxin pharmaceutical formulation comprising a botulinum toxin and a low molecular weight recombinant or native gelatin fragment suitable for administration to a human patient, and methods for treating patients with various diseases and afflictions using the formulation.
    Type: Application
    Filed: November 29, 2005
    Publication date: May 18, 2006
    Inventor: Terrence Hunt
  • Polysaccharide containing botulinum toxin pharmaceutical compositions and uses thereof
    Publication number: 20060099227
    Abstract: This invention relates to the use of a composition comprising a polysaccharide and a botulinum toxin for reducing a skin wrinkle. In some embodiments, the polysaccharide comprises disaccharides. In some embodiments, the average molecular weight of a disaccharide unit of the polysaccharide is between about 345 D and about 1,000 D.
    Type: Application
    Filed: December 13, 2005
    Publication date: May 11, 2006
    Inventor: Terrence Hunt
  • Recombinant stabilizer botulinum toxin pharmaceutical compositions
    Publication number: 20050238663
    Abstract: A botulinum toxin pharmaceutical formulation free of animal derived proteins, comprising a botulinum toxin and a recombinant albumin, suitable for therapeutic administration to a human patient, and methods for treating patients with various diseases and afflictions with the formulation.
    Type: Application
    Filed: October 29, 2004
    Publication date: October 27, 2005
    Inventor: Terrence Hunt
  • Botulinum toxin pharmaceutical compositions with enhanced potency with regard to a reference botulinum toxin pharmaceutical composition
    Publication number: 20050238667
    Abstract: A botulinum toxin pharmaceutical formulation free of animal derived proteins, comprising a botulinum toxin and a recombinant albumin, suitable for therapeutic administration to a human patient, and methods for treating patients with various diseases and afflictions with the formulation.
    Type: Application
    Filed: February 17, 2005
    Publication date: October 27, 2005
    Applicant: ALLERGAN, INC.
    Inventor: Terrence Hunt
  • Botulinum toxin pharmaceutical compositions with multiple stabilizers
    Publication number: 20050238664
    Abstract: A botulinum toxin pharmaceutical formulation free of animal derived proteins, comprising a botulinum toxin and a recombinant albumin, suitable for therapeutic administration to a human patient, and methods for treating patients with various diseases and afflictions with the formulation.
    Type: Application
    Filed: October 29, 2004
    Publication date: October 27, 2005
    Inventor: Terrence Hunt
  • Amino acid and zinc containing botulinum toxin pharmaceutical compositions
    Publication number: 20050214326
    Abstract: A botulinum toxin pharmaceutical formulation free of animal derived proteins, comprising a botulinum toxin and a recombinant albumin, suitable for therapeutic administration to a human patient, and methods for treating patients with various diseases and afflictions with the formulation.
    Type: Application
    Filed: October 29, 2004
    Publication date: September 29, 2005
    Inventor: Terrence Hunt
  • Botulinum toxin pharmaceutical composition with enhanced potency
    Publication number: 20050208076
    Abstract: A botulinum toxin pharmaceutical formulation free of animal derived proteins, comprising a botulinum toxin and a recombinant albumin, suitable for therapeutic administration to a human patient, and methods for treating patients with various diseases and afflictions with the formulation.
    Type: Application
    Filed: February 17, 2005
    Publication date: September 22, 2005
    Applicant: ALLERGAN, INC.
    Inventor: Terrence Hunt
  • Botulinum toxin pharmaceutical composition
    Publication number: 20050143289
    Abstract: A botulinum toxin pharmaceutical formulation free of animal derived proteins, comprising a botulinum toxin and a recombinant albumin, suitable for therapeutic administration to a human patient, and methods for treating patients with various diseases and afflictions with the formulation.
    Type: Application
    Filed: February 25, 2005
    Publication date: June 30, 2005
    Applicant: ALLERGAN, INC.
    Inventor: Terrence Hunt